Ethiopia & Gilead Sciences

Ethiopia: Ethiopia>>> is one of ten African countries identified by the United States — Centers for Disease Control and Prevention>>> as being at risk of Ebola infection due to the regional spread.

Gilead Sciences: Gilead Sciences' experimental oral COVID antiviral drug, Obeldesivir, is being considered for use as a preventative treatment for Ebola contacts, under strict protocol.

Ethiopia: Ethiopia>>> is one of ten African countries identified by the United States — Centers for Disease Control and Prevention>>> as being at elevated risk of Ebola transmission due to cross-border population movement.

Gilead Sciences: Gilead Sciences' antiviral drug remdesivir and experimental drug obeldesivir are being prioritized for clinical trials to treat or prevent the Bundibugyo ebolavirus, indicating its significant role in potential therapies.

Ethiopia: Ethiopia is hosting the headquarters of the African counterpart to the European Union — European Centre for Disease Prevention and Control, where an expert is being deployed.

Gilead Sciences: Gilead Sciences is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.